Spots Global Cancer Trial Database for childhood central nervous system germ cell tumor

Every month we try and update this database with for childhood central nervous system germ cell tumor cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization
FR901228 in Treating Children With Refractory or Recurrent Solid Tumors or Leukemia	NCT00053963	Blastic Phase C... Childhood Centr... Childhood Choro... Childhood Chron... Childhood Crani... Childhood Grade... Childhood Grade... Childhood Grade... Childhood High-... Childhood Infra... Childhood Low-g... Childhood Spina... Childhood Supra... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Refractory Chro... Relapsing Chron... Unspecified Chi...	romidepsin	- 21 Years	National Cancer Institute (NCI)
Acupressure in Controlling Nausea in Young Patients Receiving Highly Emetogenic Chemotherapy	NCT01346267	Central Nervous... Chemotherapy-in... Unspecified Chi...	Real Acupressur... Placebo Acupres...	4 Years - 18 Years	University of South Florida
Temozolomide and O6-Benzylguanine in Treating Children With Recurrent Brain Tumors	NCT00052780	Childhood Centr... Childhood Choro... Childhood Crani... Childhood Epend... Childhood Grade... Childhood Grade... Childhood Grade... Childhood High-... Childhood High-... Childhood Infra... Childhood Low-g... Childhood Low-g... Childhood Medul... Childhood Mixed... Childhood Oligo... Childhood Supra... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child...	O6-benzylguanin... temozolomide filgrastim pharmacological... laboratory biom...	- 21 Years	National Cancer Institute (NCI)
Rebeccamycin Analogue in Treating Children With Solid Tumors or Non-Hodgkin's Lymphoma	NCT00006102	Brain and Centr... Lymphoma Neuroblastoma Retinoblastoma Sarcoma Unspecified Chi...	becatecarin	- 21 Years	National Cancer Institute (NCI)
Photodynamic Therapy With Porfimer Sodium in Treating Patients With Refractory Brain Tumors	NCT00002647	Brain and Centr... Metastatic Canc...	verteporfin conventional su...	3 Years - 70 Years	National Cancer Institute (NCI)
Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation or Bone Marrow Transplantation in Treating Patients With Brain Cancer	NCT00025558	Brain and Centr...	filgrastim carboplatin temozolomide thiotepa autologous bone... peripheral bloo...	1 Year - 49 Years	NYU Langone Health
Combination Chemotherapy and Radiation Therapy in Treating Patients With Germ Cell Tumors in the Brain	NCT00293358	Brain and Centr...	carboplatin cisplatin etoposide phosp... ifosfamide adjuvant therap... conventional su... neoadjuvant the... radiation thera...	-	National Cancer Institute (NCI)
Pazopanib Hydrochloride in Treating Young Patients With Solid Tumors That Have Relapsed or Not Responded to Treatment	NCT00929903	Childhood Centr... Childhood Centr... Childhood Centr... Childhood Centr... Childhood Centr... Childhood Centr... Childhood Centr... Metastatic Chil... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Unspecified Chi...	pazopanib hydro... pharmacological...	2 Years - 25 Years	National Cancer Institute (NCI)
High-Dose Thiotepa Plus Peripheral Stem Cell Transplantation in Treating Patients With Refractory Solid Tumors	NCT00003173	Brain and Centr... Childhood Germ ... Extragonadal Ge... Ovarian Cancer Retinoblastoma Testicular Germ... Unspecified Adu... Unspecified Chi...	filgrastim thiotepa autologous bone... peripheral bloo...	-	Memorial Sloan Kettering Cancer Center
Imatinib Mesylate With or Without Radiation Therapy in Treating Young Patients With Newly Diagnosed or Recurrent Glioma	NCT00021229	Brain and Centr...	imatinib mesyla... local irradiati...	3 Years - 21 Years	National Cancer Institute (NCI)
Imatinib Mesylate With or Without Radiation Therapy in Treating Young Patients With Newly Diagnosed or Recurrent Glioma	NCT00021229	Brain and Centr...	imatinib mesyla... local irradiati...	3 Years - 21 Years	National Cancer Institute (NCI)
Cisplatin and Etoposide Prior to Radiation Therapy in Treating Patients With CNS Tumors	NCT00002472	Brain and Centr... Pediatric Germ ... Extragonadal Ge...	cisplatin etoposide conventional su... neoadjuvant the... radiation thera...	3 Years -	Mayo Clinic
O6-benzylguanine and Carmustine in Treating Children With Refractory CNS Tumors	NCT00003765	Brain and Centr...	O6-benzylguanin... carmustine	- 21 Years	National Cancer Institute (NCI)
Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation or Bone Marrow Transplantation in Treating Patients With Brain Cancer	NCT00025558	Brain and Centr...	filgrastim carboplatin temozolomide thiotepa autologous bone... peripheral bloo...	1 Year - 49 Years	NYU Langone Health
Acupressure in Controlling Nausea in Young Patients Receiving Highly Emetogenic Chemotherapy	NCT01346267	Central Nervous... Chemotherapy-in... Unspecified Chi...	Real Acupressur... Placebo Acupres...	4 Years - 18 Years	University of South Florida
Combination Chemotherapy Followed by Bone Marrow and/or Peripheral Stem Cell Transplantation in Treating Patients With Recurrent Medulloblastoma or CNS Germ Cell Tumors	NCT00002594	Brain Tumor Central Nervous...	Sargramostim cyclophosphamid... melphalan autologous bone... bone marrow abl... peripheral bloo...	2 Years - 25 Years	Children's Oncology Group
VNP40101M in Treating Young Patients With Recurrent, Progressive, or Refractory Primary Brain Tumors	NCT00098761	Brain and Centr...	laromustine	- 21 Years	Pediatric Brain Tumor Consortium
Autologous Peripheral Blood Stem Cell Transplant for Germ Cell Tumors	NCT00432094	Childhood Germ ... Ovarian Cancer Teratoma	carboplatin etoposide ifosfamide paclitaxel thiotepa autologous hema... Mesna filgrastim	10 Years - 69 Years	Masonic Cancer Center, University of Minnesota
Acupressure in Controlling Nausea in Young Patients Receiving Highly Emetogenic Chemotherapy	NCT01346267	Central Nervous... Chemotherapy-in... Unspecified Chi...	Real Acupressur... Placebo Acupres...	4 Years - 18 Years	University of South Florida
Erlotinib Alone or in Combination With Radiation Therapy in Treating Young Patients With Refractory or Relapsed Malignant Brain Tumors or Newly Diagnosed Brain Stem Glioma	NCT00360854	Brain and Centr...	erlotinib hydro... mutation analys... polymorphism an... laboratory biom... pharmacological... radiation thera...	1 Year - 21 Years	National Cancer Institute (NCI)
VNP40101M in Treating Young Patients With Recurrent, Progressive, or Refractory Primary Brain Tumors	NCT00098761	Brain and Centr...	laromustine	- 21 Years	Pediatric Brain Tumor Consortium
Cisplatin and Etoposide Prior to Radiation Therapy in Treating Patients With CNS Tumors	NCT00002472	Brain and Centr... Pediatric Germ ... Extragonadal Ge...	cisplatin etoposide conventional su... neoadjuvant the... radiation thera...	3 Years -	Mayo Clinic
Sunitinib in Treating Young Patients With Refractory Solid Tumors	NCT00387920	Central Nervous... Childhood Centr... Childhood Centr... Childhood Centr... Childhood Centr... Childhood Centr... Childhood Centr... Childhood Centr... Recurrent Child... Unspecified Chi...	sunitinib malat... pharmacological... dynamic contras... laboratory biom...	2 Years - 21 Years	National Cancer Institute (NCI)
Ispinesib in Treating Young Patients With Relapsed or Refractory Solid Tumors or Lymphoma	NCT00363272	Childhood Burki... Childhood Centr... Childhood Choro... Childhood Crani... Childhood Grade... Childhood Grade... Childhood Grade... Childhood High-... Childhood Infra... Childhood Low-g... Childhood Spina... Childhood Supra... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Unspecified Chi...	ispinesib laboratory biom... pharmacological...	1 Year - 21 Years	National Cancer Institute (NCI)
PTC299 in Treating Young Patients With Refractory or Recurrent Primary Central Nervous System Tumors	NCT01158300	Brain and Centr...	VEGF inhibitor ...	3 Years - 21 Years	Pediatric Brain Tumor Consortium
SU5416 in Treating Children With Recurrent or Progressive Brain Tumors	NCT00006247	Brain and Centr...	semaxanib	- 21 Years	Pediatric Brain Tumor Consortium
Radiation Therapy Compared With Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Primary Central Nervous System (CNS) Germ Cell Tumor	NCT00085098	Brain Tumor Central Nervous...	filgrastim carboplatin cisplatin cyclophosphamid... etoposide radiation thera...	3 Years - 25 Years	Children's Oncology Group
Sodium Thiosulfate in Preventing Hearing Loss in Young Patients Receiving Cisplatin for Newly Diagnosed Germ Cell Tumor, Hepatoblastoma, Medulloblastoma, Neuroblastoma, Osteosarcoma, or Other Malignancy	NCT00716976	Brain Tumor Central Nervous... Childhood Germ ... Extragonadal Ge... Liver Cancer Neuroblastoma Ototoxicity Ovarian Cancer Sarcoma	sodium thiosulf... examination	1 Year - 18 Years	Children's Oncology Group
Temozolomide and O6-Benzylguanine in Treating Children With Recurrent Brain Tumors	NCT00052780	Childhood Centr... Childhood Choro... Childhood Crani... Childhood Epend... Childhood Grade... Childhood Grade... Childhood Grade... Childhood High-... Childhood High-... Childhood Infra... Childhood Low-g... Childhood Low-g... Childhood Medul... Childhood Mixed... Childhood Oligo... Childhood Supra... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child...	O6-benzylguanin... temozolomide filgrastim pharmacological... laboratory biom...	- 21 Years	National Cancer Institute (NCI)
Chemotherapy and Vaccine Therapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation and Interleukin-2 in Treating Patients With Recurrent or Refractory Brain Cancer	NCT00014573	Brain and Centr...	aldesleukin autologous tumo... filgrastim sargramostim therapeutic aut... carmustine cisplatin cyclophosphamid... paclitaxel autologous bone... conventional su... peripheral bloo...	- 65 Years	Barbara Ann Karmanos Cancer Institute
Cilengitide in Treating Children With Refractory Primary Brain Tumors	NCT00063973	Childhood Centr... Childhood Choro... Childhood Crani... Childhood Epend... Childhood Grade... Childhood Grade... Childhood Grade... Childhood High-... Childhood High-... Childhood Infra... Childhood Low-g... Childhood Low-g... Childhood Medul... Childhood Mixed... Childhood Oligo... Childhood Supra... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child...	cilengitide laboratory biom...	- 21 Years	National Cancer Institute (NCI)
Neoadjuvant Chemotherapy With or Without Second-Look Surgery Followed by Radiation Therapy With or Without Peripheral Stem Cell Transplantation in Treating Patients With Intracranial Germ Cell Tumors	NCT00047320	Brain Tumor Central Nervous... Childhood Germ ...	carboplatin etoposide ifosfamide thiotepa adjuvant therap... conventional su... neoadjuvant the... peripheral bloo... radiation thera...	3 Years - 24 Years	Children's Oncology Group
Pazopanib Hydrochloride in Treating Young Patients With Solid Tumors That Have Relapsed or Not Responded to Treatment	NCT00929903	Childhood Centr... Childhood Centr... Childhood Centr... Childhood Centr... Childhood Centr... Childhood Centr... Childhood Centr... Metastatic Chil... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Unspecified Chi...	pazopanib hydro... pharmacological...	2 Years - 25 Years	National Cancer Institute (NCI)
FR901228 in Treating Children With Refractory or Recurrent Solid Tumors or Leukemia	NCT00053963	Blastic Phase C... Childhood Centr... Childhood Choro... Childhood Chron... Childhood Crani... Childhood Grade... Childhood Grade... Childhood Grade... Childhood High-... Childhood Infra... Childhood Low-g... Childhood Spina... Childhood Supra... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Refractory Chro... Relapsing Chron... Unspecified Chi...	romidepsin	- 21 Years	National Cancer Institute (NCI)
Combination Chemotherapy Followed by Bone Marrow and/or Peripheral Stem Cell Transplantation in Treating Patients With Recurrent Medulloblastoma or CNS Germ Cell Tumors	NCT00002594	Brain Tumor Central Nervous...	Sargramostim cyclophosphamid... melphalan autologous bone... bone marrow abl... peripheral bloo...	2 Years - 25 Years	Children's Oncology Group
Temozolomide and O6-Benzylguanine in Treating Children With Recurrent Brain Tumors	NCT00052780	Childhood Centr... Childhood Choro... Childhood Crani... Childhood Epend... Childhood Grade... Childhood Grade... Childhood Grade... Childhood High-... Childhood High-... Childhood Infra... Childhood Low-g... Childhood Low-g... Childhood Medul... Childhood Mixed... Childhood Oligo... Childhood Supra... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child...	O6-benzylguanin... temozolomide filgrastim pharmacological... laboratory biom...	- 21 Years	National Cancer Institute (NCI)
Combination Chemotherapy in Treating Young Patients With Advanced Solid Tumors	NCT00281944	Childhood Centr... Childhood Centr... Childhood Centr... Childhood Centr... Childhood Centr... Childhood Centr... Childhood Centr... Recurrent Child... Recurrent Child... Unspecified Chi...	oxaliplatin fluorouracil leucovorin calc... pharmacological... positron emissi... computed tomogr...	- 21 Years	National Cancer Institute (NCI)
Acetylcysteine, Mannitol, Combination Chemotherapy, and Sodium Thiosulfate in Treating Children With Malignant Brain Tumors	NCT00238173	Bone Marrow Sup... Brain and Centr... Drug/Agent Toxi... Long-term Effec...	filgrastim acetylcysteine carboplatin cyclophosphamid... etoposide phosp... mannitol sodium thiosulf...	1 Year - 18 Years	OHSU Knight Cancer Institute
Combination Chemotherapy and Radiation Therapy in Treating Patients With Germ Cell Tumors in the Brain	NCT00293358	Brain and Centr...	carboplatin cisplatin etoposide phosp... ifosfamide adjuvant therap... conventional su... neoadjuvant the... radiation thera...	-	National Cancer Institute (NCI)
Combination Chemotherapy in Treating Young Patients With Advanced Solid Tumors	NCT00281944	Childhood Centr... Childhood Centr... Childhood Centr... Childhood Centr... Childhood Centr... Childhood Centr... Childhood Centr... Recurrent Child... Recurrent Child... Unspecified Chi...	oxaliplatin fluorouracil leucovorin calc... pharmacological... positron emissi... computed tomogr...	- 21 Years	National Cancer Institute (NCI)

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

Join others from around the world: